Eli Lilly & Co. Blog Posts

More patients help drug firms pass 'valley of death'

August 11, 2014
Comment(1)
In spite of the beaucoup bucks in the pharma sector, patients, along with their families and committed advocates, are turning out to be better sources of funding for early stage companies because they tolerate risk better than drug companies and investors.
More

Most drug money in Indiana funds research. Is that good?

July 28, 2014
Comment(1)
With federal research funding declining, drug companies are taking a larger role funding the medical research happening at IU and universities around the country. That's not the same thing as paying to market drugs, but it's hardly without controversy.
More

Indy patients love their doctors

July 14, 2014
Comments(0)
Indianapolis ranked fifth highest among the nation’s largest cities for the most positive reviews of physicians. On a five-point Patient Happiness Index, the average review by patients scored Indianapolis physicians at a 4.05. San Francisco physicians topped the list.
More

Doctors' drug money

July 10, 2014
Comments(9)
Indiana physicians and research organizations reaped more than $25 million in payments from 15 pharmaceutical firms in 2012, according to the most recent data made available by the not-for-profit group ProPublica. Lilly was the biggest spender and the IU medical school was the biggest recipient.
More

Five things I learned from the Medicare doctor payments

April 10, 2014
Comments(11)
From this week's historic data dump, I learned who the top 20 recipients of Medicare payments are in Indianapolis (hint: mostly labs, ambulances and eye surgeons). But the real takeaway is that meaningful price information about doctors is still a long way away.
More

Lilly shares hit all-time high for the John Lechleiter era

April 7, 2014
Comments(2)
Court win last week in a patent challenge to lung cancer drug Alimta pushed Lilly shares higher than they've ever been since April 2007. Since then, the company’s pipeline has produced more misfires than the villains in a James Bond movie
More

Life sciences jobs pack 2-for-1 punch

February 24, 2014
Comments(2)
While life sciences companies don’t rack up huge jobs numbers, their relatively high pay means that every job they create is worth two in the rest of the private sector.
More

No one likes Obamacare

January 2, 2014
Comments(15)
Obamacare has officially arrived, but both conservatives and liberals are calling it awful. That means the real debate over health reform is just beginning.
More

Health care has priced itself out of its own market

November 18, 2013
Comments(11)
It’s no secret the growth of the U.S. economy slowed in the 2000s after the go-go decade preceding it. But the U.S. health care system—hospitals, doctors, drug companies, device makers and health insurers—apparently didn’t get that memo.
More

The bill for Hoosiers’ excess health care spending: About $5 billion per year

November 11, 2013
Comments(9)
Hoosiers' poor health, combined with an aggressive health care system and an uncompetitive health insurance sector, means Hoosiers, in spite of the fact that they earn just 86 cents for every dollar earned by the average American, are spending nearly $1.13 on health care for every dollar spent by Americans.
More

Finding where the money is in health care

October 14, 2013
Comments(9)
More than half of the $2.5 trillion consumers spend annually on health care in the United States flows to hospitals and doctors, with drug companies and health insurers trailing well behind.
More

Me-too diabetes drugs look good enough for Lilly

June 26, 2013
Comments(2)
Eli Lilly and Co. is more than 15 years late to the game in the world of diabetes drugs. And it isn’t bringing much that doctors and patients haven’t already seen. Still, that might be good enough to make a few billion a year.
More

ADVERTISEMENT
Sponsored by
ADVERTISEMENT
  1. In response to Sassafras, I have to ask if you relocated directly from Bloomington to Carmel? First, as you point out, Carmel is 48 square miles. Do you think it’s possible that some areas are more densely developed than others? That might explain traffic density in some places while others are pretty free moving. Second, your comment “have you ever been to Chicago--or just about any city outside of Indiana?” belies your bias. I don’t know, Sassafras, have you never been to Nashville, Columbus, OH, Cincinnati, St. Louis, Kansas City, Denver, Phoenix? They’re not a lot different in density than Indy. One more thing…I understand these comment sections are for expressing opinions, so those of us just looking for facts have to be patient, but you mention “low-density” Indy. How many cities in the US comprise 400 square miles with about 10% of that still being agricultural? Those facts certainly can impact the statistics.

  2. With all the past shady actions of Duke with utility regulators, one wonders do they really need such a huge amount? Concerned regulators not protecting ratepayers from the aggressive Duke monolith.

  3. I thought that had to be the way it was but had to ask because I wasn't sure. Thanks Again!

  4. I could be wrong, but I don't think Butler views the new dorm as mere replacements for Schwitzer and or Ross.

  5. An increase of only 5% is awesome compared to what most consumers face or used to face before passage of the ACA. Imagine if the Medicaid program had been expanded to the 400k Hoosiers that would be eligible, the savings would have been substantial to the state and other policy holders. The GOP predictions of plan death spirals, astronomical premium hikes and shortages of care are all bunk. Hopefully voters are paying attention. The Affordable Care Act (a.k.a Obamacare), where fully implemented, has dramatically reduced the number of uninsured and helped contained the growth in healthcare costs.

ADVERTISEMENT